International network of cancer genome projects
Международная сеть проектов по исследованию геномов рака
2010-04-13
SCID: 54.1/gsh93tpz
Discuss with AI
International Cancer Genome Consortiumcancer genome sequencingcancer genome studiesepigenomic and transcriptomic profilingoncogenic mutations
Figures from the paper
Abstract (AI)
Hundreds of individual human cancer genome sequences are expected to be published in 2010, and thousands per year after that. The International Cancer Genome Consortium (ICGC) was launched with the aim of keeping track of the data relating to large-scale cancer genome studies of all major cancers in adults and children — a total of 50 different cancer types and/or subtypes. In this issue the ICGC team ( http://www.icgc.org ) spells out the policies and planning for the project. The International Cancer Genome Consortium (ICGC) was launched to coordinate large-scale cancer genome studies in tumours from 50 different cancer types and/or subtypes that are of clinical and societal importance across the globe. Systematic studies of more than 25,000 cancer genomes at the genomic, epigenomic and transcriptomic levels will reveal the repertoire of oncogenic mutations, uncover traces of the mutagenic influences, define clinically relevant subtypes for prognosis and therapeutic management, and enable the development of new cancer therapies.
Key Findings
1
Systematic analysis of more than 25,000 cancer genomes at genomic, epigenomic, and transcriptomic levels is planned.
2
The International Cancer Genome Consortium was launched to coordinate large-scale genome studies across 50 clinically and societally important cancer types and subtypes.
3
The consortium established policies and planning for tracking data from international cancer genome projects involving adults and children.
4
The resulting data are intended to improve prognosis and therapeutic management and support development of new cancer treatments.
5
The studies aim to catalogue oncogenic mutations, identify mutagenic influences, and define clinically relevant cancer subtypes.
Research Object
Human cancer genomes and tumours spanning 50 major cancer types and/or subtypes
Research Subject
Their genomic, epigenomic and transcriptomic alterations, including oncogenic mutations, mutagenic signatures, clinically relevant subtypes, and therapeutic implications
Publication Details
Publication Date
2010-04-13
Journal
Publisher
ISSN
Cited by
2342
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai1
Cited by6
COSMIC: the Catalogue Of Somatic Mutations In Cancer2018
COSMIC: exploring the world's knowledge of somatic mutations in human cancer2014
Early detection of cancer2022
Deep learning in cancer diagnosis, prognosis and treatment selection2021
DUET: a server for predicting effects of mutations on protein stability using an integrated computational approach2014
Pan-cancer analysis of whole genomes2020